Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mario Negri Institute for Pharmacological Research
Oslo University Hospital
Oslo University Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Pfizer
Dana-Farber Cancer Institute
Shanghai Pharma Biotherapeutics USA Inc.
Memorial Sloan Kettering Cancer Center
Columbia University
Fox Chase Cancer Center
Alliance for Clinical Trials in Oncology
Pfizer
Fudan University
Columbia University
Sarcoma Alliance for Research through Collaboration
Washington University School of Medicine
National Cancer Institute (NCI)
Canadian Cancer Trials Group
Dana-Farber Cancer Institute
Northwestern University
Brown University
Italian Sarcoma Group
OHSU Knight Cancer Institute
European Organisation for Research and Treatment of Cancer - EORTC
Brown University
Institut Bergonié
Maria Sklodowska-Curie National Research Institute of Oncology
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
Vector Oncology
Hadassah Medical Organization
Novartis
Memorial Sloan Kettering Cancer Center
Infinity Pharmaceuticals, Inc.
Merck Sharp & Dohme LLC
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC